Sun Yat-sen University: all 1,680 studies

Page 4 of 17. Open to participants first (609), then studies with results posted, then the rest; newest registration first within each.

• dTACE-HAIC Combined With Bevacizumab and Atezolizumab for Huge Hepatocellular CarcinomaRecruitingNCT06609863Not applicable
• The Comparison of TACE-Lenvatinib With TACE-Lenvatinib-ablation for Intermediate Recurrent Hepatocellular CarcinomaRecruitingNCT06609850Not applicable
• GP Combined with Toripalimab Versus GP Induction Chemotherapy for Advanced Childhood Nasopharyngeal CarcinomaNot yet recruitingNCT06605131Phase 2
• Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic TreatmentNot yet recruitingNCT06592612Phase 2
• Modified Orbital Decompression in the Treatment of Moderate-to-severe Grave's OphthalmopathyRecruitingNCT06588764Not applicable
• Phase II Study of PD-1 Antibody Combined With Radiotherapy in Recurrent or Metastatic Adrenal Cortical CarcinomaRecruitingNCT06587802Phase 2
• Sintilimab With P-GEMOX Versus the P-GEMOX in the Teatment of Advanced-stage Extranodal Natural Killer/T Cell LymphomaRecruitingNCT06583083Phase 2
• Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain MetastasisRecruitingNCT06582940Phase 2
• Photoacoustic Tomography in Assessment of Lower Extremity Artery DiseaseRecruitingNCT06579326
• Neoadjuvant RC48 Plus Carboplatin for HER2-expressing Advanced Ovarian CancerNot yet recruitingNCT06574763Phase 2
• A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma PatientsRecruitingNCT06569485Phase 2
• Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations.RecruitingNCT06563999Phase 2
• TPC VS. GP Induced Chemotherapy Combined With Nimotuzumab and Toripalimab in the Treatment of Locally Advanced Nasopharyngeal CarcinomaNot yet recruitingNCT06561763Phase 3
• Individualized Tumor-Informed CtDNA Analysis for Monitoring Postoperative Recurrence in ESCC (NEOCRTEC2401)RecruitingNCT06561178
• Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression PatternsRecruitingNCT06551220
• Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular CarcinomaRecruitingNCT06550921Not applicable
• Cetuximab, Irinotecan, Toripalimab in RAS/BRAF Wild-type Ultraselected Right-sided Colorectal Cancer StudyRecruitingNCT06547203Phase 2
• Adaptive Hypofractionated Radiotherapy for Locally Advanced NSCLC Based on Dynamic Enhanced MRIRecruitingNCT06545747Phase 3
• Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary OligometastasesRecruitingNCT06542159Phase 2
• Endoscopic Surgery vs. Intensity Modulated Radiotherapy for Stage I Nasopharyngeal Carcinoma.RecruitingNCT06533267Not applicable
• Efficacy and Safety of Organoid-Based Drug Sensitivity Screening to Guide the Treatment of mCRPC Patients Progressed After First-line TreatmentRecruitingNCT06529549
• Adjuvant PD-1 Blockade for High-risk Stage-II DMMR/MSI-H Colorectal CancerRecruitingNCT06520683Phase 3
• Befotertinib and Icotinib for NSCLC With Uncommon EGFR MutationsRecruitingNCT06517953Phase 2
• Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial)RecruitingNCT06517511Phase 2
• Online Adaptive Radiotherapy for Nasopharyngeal CarcinomaRecruitingNCT06516133Phase 3
• 2 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell CarcinomaRecruitingNCT06492460Phase 3
• Clinical Study of Radical Right Hemicolectomy Versus Radical Right Hemicolectomy Combined with Indocyanine Green Fluorescence Imaging Lymphatic Tracer Dissection for the Treatment of Right Colon CancerRecruitingNCT06485609Not applicable
• HAIC Combined With Adebrelimab Plus Apatinib as the First-line Treatment for HCC in BCLC Stage C: An Open-label, Single-arm, Phase II StudyNot yet recruitingNCT06482008Phase 2
• The Effect of GM-CSF to Preventing Oral Mucositis for Patients With Nasopharyngeal Carcinoma Receiving RadiotherapyRecruitingNCT06472739Phase 2
• Neoadjuvant HAIC and PD-1 Plus Adjuvant PD-1 for High-risk Recurrent HCCRecruitingNCT06467799Phase 2
• Promoting Atrial Fibrillation Screening in Primary CareNot yet recruitingNCT06458829Not applicable
• Effectiveness of Pucotenlimab Combined With Standard Chemotherapy RegimenRecruitingNCT06456892Phase 1/2
• GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal CarcinomaRecruitingNCT06455410Phase 2
• Neoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric CancerRecruitingNCT06451211Phase 2
• Fruquintinib After ICIs Treatment in Unresectable Hepatocellular CarcinomaRecruitingNCT06446154Phase 2
• Diagnostic Accuracy of EBV C Promoter Methylation Kit in Nasopharyngeal CarcinomaRecruitingNCT06445088
• Fruquintinib With or Without HAI-FOLFOX for Refractory Colorectal CancerRecruitingNCT06441565Phase 2/3
• Hematoporphyrin Photodynamic Therapy for Esophageal CancerEnrolling by invitationNCT06437288Phase 4
• Liposomal Irinotecan Plus Bevacizumab in Irinotecan-refractory Metastatic Colorectal CancerNot yet recruitingNCT06434090Phase 1/2
• The Efficacy of Bevacizumab and Serplulimab Combined With Recombinant Mutant HumanTumor Necrosis Factor(rmhTNF-NC) in the Treatment of Malignant AscitesRecruitingNCT06433869Phase 2
• Liposomal Bupivacaine vs Ropivacaine for TAPBsRecruitingNCT06430112Phase 3
• Anlotinib Combined With Benmelstobart for Advanced PheochromocytomaNot yet recruitingNCT06429397Phase 2
• ctDNA-MRD Guided Consolidation Toripalimab in Stage IB-IIIA NSCLCRecruitingNCT06426511Phase 2
• Prebiotics and the Management of HyperuricemiaRecruitingNCT06420401Not applicable
• A Prospective Study: Sintilimab and R-CHOP in PMBCL TreatmentNot yet recruitingNCT06412068Phase 2
• Safety & Efficacy of Peg-ASP-based CCRT in Early Stage ENKTLRecruitingNCT06406556Phase 2
• A Prospective, Randomized, Open, Parallel-controlled, Superior-efficacy Clinical Study of Radical Sigmoidectomy for Sigmoid Cancer Versus Radical Sigmoidectomy Combined with Indocyanine Green Fluorescence Imaging Lymphatic Tracing Dissection in the Treatment of Sigmoid CancerEnrolling by invitationNCT06396806Not applicable
• PD-1 Antibody and Sapropterin Dihydrochloride in Patients With PDACRecruitingNCT06396637Phase 2
• Supraclavicular Lymph Node Dissection for Ipsilateral Supraclavicular Lymph Node Metastatic Breast CancerNot yet recruitingNCT06383663Not applicable
• Flexible Colonoscope Assisted Hybrid Transanal Total Mesorectal Resection (taTME)RecruitingNCT06380855
• BAI-BACE for Advanced Lung Squamous Cell CarcinomaRecruitingNCT06377735Not applicable
• KSD-101 Therapy for Standard Treatment Failed EBV-associated NPC: an Exploratory Clinical TrialNot yet recruitingNCT06370026Early Phase 1
• A Randomized Controlled Trial of the Safety and Efficacy of Robotic Telesurgery Versus Laparoscopic SurgeryNot yet recruitingNCT06369597Not applicable
• Effects of Supplementation of Compound Nutrients on Plasma Homocysteine in Chinese AdultsRecruitingNCT06363565Not applicable
• Artificial Intelligence-supported Reading Versus Standard Double Reading for the Interpretation of Magnetic Resonance Imaging in the Detection of Local Recurrence for Nasopharyngeal Carcinoma: a Randomised Controlled Multicenter StudyNot yet recruitingNCT06356441
• Adebrelimab and Chemoradiotherapy in High-risk LANPCRecruitingNCT06349889Phase 2
• HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular CarcinomaRecruitingNCT06333561
• Locoregional Therapy Combined With Bevacizumab and PD1/L1 Inhibitor in Advanced Hepatocellular CarcinomaRecruitingNCT06323382
• SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal CarcinomaRecruitingNCT06323239Phase 2
• De-escalated Radiotherapy for Primary Tumor After Neoadjuvant Therapy With Toripalimab Plus Chemotherapy for Nasopharyngeal CarcinomaRecruitingNCT06313450Not applicable
• Combination of SBRT and Immunotherapy in Small Hepatocellular Carcinoma (HSBRT2402)RecruitingNCT06313190Phase 2
• TPC Versus GP Induction Chemotherapy for Nasopharyngeal CarcinomaRecruitingNCT06301165Phase 2
• Myeloprotection With Trilaciclib in Pan-cancer PopulationNot yet recruitingNCT06297811Phase 2
• Factors Associated With Posttransplant Cardiac OutcomesRecruitingNCT06290154
• Adolescents' Non-suicidal Behavior and Perception of Parents' Negative Emotional Expression and Family CommunicationNot yet recruitingNCT06290115
• Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC PatientsRecruitingNCT06280495Phase 2/3
• Patient Derived Organoid-guided Personalized Treatment Versus Treatment of Physician's Choice in Breast CancerRecruitingNCT06268652Phase 3
• Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary MetastasesRecruitingNCT06265350Not applicable
• Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before SurgeryRecruitingNCT06262581Phase 2
• Individualized Elective Neck Irradiation in NPC PatientsRecruitingNCT06241612Phase 3
• A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)RecruitingNCT06241599Phase 2/3
• Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment ResponseRecruitingNCT06239727Phase 3
• A Study of the Treatment of Disitamab Vedotin in Patients With Locally Advanced or Metastatic Pancreatic CancerNot yet recruitingNCT06233864Phase 2
• Effects of Digital Therapeutic in Whole Process Management of Lung CancerRecruitingNCT06230445Phase 3
• Enhanced External Counter Pulsation on Afterload Mismatch Rate in Post-TEER (PAMPER)Not yet recruitingNCT06227286Not applicable
• SBRT Followed by Neoadjuvant Chemoimmunotherapy of Sindilizumab Plus Docetaxel and Cisplatin for Locoregionally Advanced Squamous Carcinoma of Oral Cavity and OropharynxRecruitingNCT06219980Phase 2
• Localized Treatment Versus Palliative Chemotherapy in CRC Patients With 10 or More CRLMRecruitingNCT06208371Phase 3
• Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid TumorsRecruitingNCT06206681
• MRD-guided Deferred Adjuvant Therapy in Resectable Early-stage Colon CancerRecruitingNCT06204484Not applicable
• Epstein-Barr Virus and Cancer RisksRecruitingNCT06203314
• Evaluation of Phacogoniotomy in Medically-controlled POAGRecruitingNCT06201455Not applicable
• FOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind TrialRecruitingNCT06201065Phase 3
• Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPCRecruitingNCT06197776
• Serum Estradiol (E2) Levels in Breast Cancer Patients During Endocrine Therapy by High Performance Liquid Chromatography-tandem Mass Spectrometry (LC-MS /MS)RecruitingNCT06195202
• Consolidation of Toripalimab After Chemoradiotherapy in Elderly Esophageal Cancer (EC-CRT-007)RecruitingNCT06187597Phase 2
• The Effect of Sodium Fluoride Application on the Prevention of Radiation Caries in NPC PatientsNot yet recruitingNCT06174012Phase 2
• Occurrence of Radiation-induced Otitis Media in Nasopharyngeal Carcinoma Patients After Intensity Modulated RadiotherapyRecruitingNCT06170021
• A Study of HAIC Combined With Lenvatinib and Envolizumab in Potentially Resectable Hepatocellular CarcinomaNot yet recruitingNCT06143579Phase 2
• PaCIFiC-CUP Classifies Cancer of Unknown PrimaryRecruitingNCT06140992
• Health Status and the Need for Social Return of Drug Abusers in Guangdong ProvinceNot yet recruitingNCT06132555
• Pucotenlimab Combined With Lenvatinib as a Neodjuvant Therapy for Non Clear Cell Renal Cell CarcinomaNot yet recruitingNCT06129955Phase 2
• The Effect of Short-term Insulin Intensive Therapy Based on the Application of Insulin Pump and Real-time Dynamic Glucose Monitoring Technology on Reversing the Newly Diagnosed Type 2 DiabetesRecruitingNCT06127433Phase 4
• Crisaborole Ointment for Skin Toxicity Induced by CetuximabRecruitingNCT06118047Phase 2
• Total Neoadjuvant Treatment for pMMR Locally Advanced Low Rectal Cancer: Anti-PD-1 Antibody With FOLFOXIRI and Preoperative Radiation TherapyNot yet recruitingNCT06099951Phase 2
• Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction ChemotherapyRecruitingNCT06092957Phase 3
• Bevacizumab in Combination With Sintilimab Versus Transcatheter Arterial Chemoembolization for the Treatment of Intermediate Stage Hepatocellular Carcinoma (Beyond Up-To-Seven Criteria)RecruitingNCT06090656Phase 2
• bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular CarcinomaRecruitingNCT06070636Not applicable
• Aortic Valve Diseases RISk facTOr assessmenT and Prognosis modeL ConstructionRecruitingNCT06069232
• First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian CancerNot yet recruitingNCT06063070Phase 2
• bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCCRecruitingNCT06061276Not applicable

← Sun Yat-sen University overview and focus areas